Spots Global Cancer Trial Database for carvedilol
Every month we try and update this database with for carvedilol cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Anti-Cancer Effects of Carvedilol With Standard Treatment in Glioblastoma and Response of Peripheral Glioma Circulating Tumor Cells | NCT03980249 | Glioblastoma Glioblastoma Mu... | Carvedilol | 18 Years - | West Virginia University | |
| Carvedilol for the Prevention of Anthracycline/Anti-HER2 Therapy Associated Cardiotoxicity Among Women With HER2-Positive Breast Cancer Using Myocardial Strain Imaging for Early Risk Stratification | NCT02177175 | Breast Cancer | Carvedilol placebo | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Carvedilol for the Prevention of Anthracycline/Anti-HER2 Therapy Associated Cardiotoxicity Among Women With HER2-Positive Breast Cancer Using Myocardial Strain Imaging for Early Risk Stratification | NCT02177175 | Breast Cancer | Carvedilol placebo | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Beta Adrenergic Receptor Blockade as a Novel Therapy for Patients With Adenocarcinoma of the Prostate | NCT02944201 | Prostate Cancer | Carvedilol | 18 Years - | Montefiore Medical Center | |
| Carvedilol for the Prevention of Anthracycline/Anti-HER2 Therapy Associated Cardiotoxicity Among Women With HER2-Positive Breast Cancer Using Myocardial Strain Imaging for Early Risk Stratification | NCT02177175 | Breast Cancer | Carvedilol placebo | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Effects of Carvedilol on Cardiotoxicity in Cancer Patients Submitted to Anthracycline Therapy | NCT04939883 | Cancer | Carvedilol Placebo | 18 Years - | Hospital Sirio-Libanes | |
| Carvedilol Effect in Preventing Chemotherapy - Induced Cardiotoxicity | NCT01724450 | Breast Cancer Heart Failure Cardiotoxicity | Carvedilol Placebo | 18 Years - | University of Sao Paulo | |
| Beta Adrenergic Receptor Blockade as a Novel Therapy for Patients With Adenocarcinoma of the Prostate | NCT02944201 | Prostate Cancer | Carvedilol | 18 Years - | Montefiore Medical Center | |
| Beta Adrenergic Receptor Blockade as a Novel Therapy for Patients With Adenocarcinoma of the Prostate | NCT02944201 | Prostate Cancer | Carvedilol | 18 Years - | Montefiore Medical Center | |
| TrAstuzumab Cardiomyopathy Therapeutic Intervention With Carvedilol | NCT03879629 | Breast Cancer | Carvedilol | 18 Years - | Mayo Clinic | |
| Anti-Cancer Effects of Carvedilol With Standard Treatment in Glioblastoma and Response of Peripheral Glioma Circulating Tumor Cells | NCT03980249 | Glioblastoma Glioblastoma Mu... | Carvedilol | 18 Years - | West Virginia University | |
| Non-selective Beta Blockers Versus EVL for Primary Prophylaxis of Esophageal Variceal Bleeding in Patients With Hepatocellular Carcinoma With Portal Vein Tumour Thrombosis. | NCT01659346 | Hepatocellular ... | Endoscopic Vari... Carvedilol | 18 Years - 65 Years | Institute of Liver and Biliary Sciences, India | |
| TrAstuzumab Cardiomyopathy Therapeutic Intervention With Carvedilol | NCT03879629 | Breast Cancer | Carvedilol | 18 Years - | Mayo Clinic | |
| Carvedilol With Chemotherapy in Second Line Glioblastoma and Response of Circulating Tumor Cells | NCT03861598 | Glioblastoma Mu... Glioblastoma | Carvedilol | 18 Years - | West Virginia University | |
| Non-selective Beta Blockers Versus EVL for Primary Prophylaxis of Esophageal Variceal Bleeding in Patients With Hepatocellular Carcinoma With Portal Vein Tumour Thrombosis. | NCT01659346 | Hepatocellular ... | Endoscopic Vari... Carvedilol | 18 Years - 65 Years | Institute of Liver and Biliary Sciences, India | |
| Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors | NCT02717507 | Hematopoietic a... Malignant Solid... | Carvedilol Laboratory Biom... Pharmacogenomic... Pharmacological... Placebo Adminis... Quality-of-Life... Questionnaire A... | - | Children's Oncology Group | |
| A Prospective Study of Breast Cancer Patients With Abnormal Strain Imaging | NCT02993198 | HER2 Positive B... Cardiovascular ... | Carvedilol | 18 Years - | Northwestern University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
